These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 25539510

  • 1. BDNF release is required for the behavioral actions of ketamine.
    Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(1):. PubMed ID: 25539510
    [Abstract] [Full Text] [Related]

  • 2. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
    Ghosal S, Bang E, Yue W, Hare BD, Lepack AE, Girgenti MJ, Duman RS.
    Biol Psychiatry; 2018 Jan 01; 83(1):29-37. PubMed ID: 28751069
    [Abstract] [Full Text] [Related]

  • 3. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine.
    Fukumoto K, Fogaça MV, Liu RJ, Duman C, Kato T, Li XY, Duman RS.
    Proc Natl Acad Sci U S A; 2019 Jan 02; 116(1):297-302. PubMed ID: 30559184
    [Abstract] [Full Text] [Related]

  • 4. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
    Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ.
    Eur Psychiatry; 2014 Sep 02; 29(7):419-23. PubMed ID: 24321772
    [Abstract] [Full Text] [Related]

  • 5. The Requirement of L-Type Voltage-Dependent Calcium Channel (L-VDCC) in the Rapid-Acting Antidepressant-Like Effects of Scopolamine in Mice.
    Yu H, Li M, Shen X, Lv D, Sun X, Wang J, Gu X, Hu J, Wang C.
    Int J Neuropsychopharmacol; 2018 Feb 01; 21(2):175-186. PubMed ID: 29020410
    [Abstract] [Full Text] [Related]

  • 6. BDNF release and signaling are required for the antidepressant actions of GLYX-13.
    Kato T, Fogaça MV, Deyama S, Li XY, Fukumoto K, Duman RS.
    Mol Psychiatry; 2018 Oct 01; 23(10):2007-2017. PubMed ID: 29203848
    [Abstract] [Full Text] [Related]

  • 7. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H, Suzuki A, Kunugi A, Tajima Y, Yamada R, Kimura H.
    Pharmacol Biochem Behav; 2021 Dec 01; 211():173289. PubMed ID: 34655652
    [Abstract] [Full Text] [Related]

  • 8. IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine.
    Deyama S, Kondo M, Shimada S, Kaneda K.
    Transl Psychiatry; 2022 May 17; 12(1):178. PubMed ID: 35577782
    [Abstract] [Full Text] [Related]

  • 9. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors.
    Sayson LV, Botanas CJ, Custodio RJP, Abiero A, Kim M, Lee HJ, Kim HJ, Yoo SY, Lee KW, Ryu HW, Acharya S, Kim KM, Lee YS, Cheong JH.
    Psychopharmacology (Berl); 2019 Jul 17; 236(7):2201-2210. PubMed ID: 30891619
    [Abstract] [Full Text] [Related]

  • 10. Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation.
    Fukumoto K, Fogaça MV, Liu RJ, Duman CH, Li XY, Chaki S, Duman RS.
    Neuropsychopharmacology; 2020 Sep 17; 45(10):1725-1734. PubMed ID: 32396921
    [Abstract] [Full Text] [Related]

  • 11. Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor.
    Deyama S, Bang E, Kato T, Li XY, Duman RS.
    Biol Psychiatry; 2019 Jul 15; 86(2):143-152. PubMed ID: 30712809
    [Abstract] [Full Text] [Related]

  • 12. Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine.
    Pham TH, Defaix C, Nguyen TML, Mendez-David I, Tritschler L, David DJ, Gardier AM.
    Pharmacol Biochem Behav; 2020 May 15; 192():172913. PubMed ID: 32201299
    [Abstract] [Full Text] [Related]

  • 13. TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats.
    Suzuki A, Murakami K, Tajima Y, Hara H, Kunugi A, Kimura H.
    Pharmacol Biochem Behav; 2019 Aug 15; 183():80-86. PubMed ID: 31202810
    [Abstract] [Full Text] [Related]

  • 14. α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor activation protects against phencyclidine-induced caspase-3 activity by activating voltage-gated calcium channels.
    Timpe JM, Wang CZ, Kim J, Johnson KM.
    J Neurosci Res; 2014 Dec 15; 92(12):1785-91. PubMed ID: 24995437
    [Abstract] [Full Text] [Related]

  • 15. Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures.
    Lepack AE, Bang E, Lee B, Dwyer JM, Duman RS.
    Neuropharmacology; 2016 Dec 15; 111():242-252. PubMed ID: 27634096
    [Abstract] [Full Text] [Related]

  • 16. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
    Yang C, Kobayashi S, Nakao K, Dong C, Han M, Qu Y, Ren Q, Zhang JC, Ma M, Toki H, Yamaguchi JI, Chaki S, Shirayama Y, Nakazawa K, Manabe T, Hashimoto K.
    Biol Psychiatry; 2018 Oct 15; 84(8):591-600. PubMed ID: 29945718
    [Abstract] [Full Text] [Related]

  • 17. Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats.
    Pałucha-Poniewiera A, Podkowa K, Pilc A.
    Behav Pharmacol; 2019 Sep 15; 30(6):471-477. PubMed ID: 30724804
    [Abstract] [Full Text] [Related]

  • 18. Induction of brain-derived neurotrophic factor by convulsant drugs in the rat brain: involvement of region-specific voltage-dependent calcium channels.
    Katoh-Semba R, Takeuchi IK, Inaguma Y, Ichisaka S, Hata Y, Tsumoto T, Iwai M, Mikoshiba K, Kato K.
    J Neurochem; 2001 Apr 15; 77(1):71-83. PubMed ID: 11279263
    [Abstract] [Full Text] [Related]

  • 19. Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.
    Liu WX, Wang J, Xie ZM, Xu N, Zhang GF, Jia M, Zhou ZQ, Hashimoto K, Yang JJ.
    Psychopharmacology (Berl); 2016 Feb 15; 233(3):405-15. PubMed ID: 26514555
    [Abstract] [Full Text] [Related]

  • 20. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
    Wei IH, Chen KT, Tsai MH, Wu CH, Lane HY, Huang CC.
    J Agric Food Chem; 2017 Dec 13; 65(49):10792-10803. PubMed ID: 29161812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.